SEARCH

SEARCH BY CITATION

References

  • Akaike A., Kaneko S., Tamura Y., Nakata N., Shiomi H., Ushikubi F. and Narumiya S. (1994) Prostaglandin E2 protects cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663, 237243.
  • An S., Yang J., So S. W., Zeng L. and Goetzl E. J. (1994) Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals. Biochemistry 33, 14 49614 502.
  • Basu A., Krady J. K. and Levison S. W. (2004) Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78, 151156.
  • Blatteis C. M., Sehic E. and Li S. (2000) Pyrogen sensing and signaling: old views and new concepts. Clin. Infect. Dis. 31, S168S177.
  • Caggiano A. O. and Kraig R. P. (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72, 565575.
  • Candelario-Jalil E., Gonzalez-Falcon A., Garcia-Cabrera M., Leon O. S. and Fiebich B. L. (2004) Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat. Brain Res. 1007, 98108.
  • Candelario-Jalil E., Slawik H., Ridelis I., Waschbisch A., Akundi R. S., Huell M. and Fiebich B. L. (2005) Regional distribution of the prostaglandin E2 receptor EP1 in the rat brain: accumulation in Purkinje cells of the cerebellum. J. Mol. Neurosci. (in press).
  • Cazevieille C., Muller A., Meynier F., Dutrait N. and Bonne C. (1994) Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem. Int. 24, 395398.
  • Chen C., Magee J. C. and Bazan N. G. (2002) Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 87, 28512857.
  • Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156159.
  • De Groot C. J., Langeveld C. H., Jongenelen C. A., Montagne L., Van Der Valk P. and Dijkstra C. D. (1997) Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J. Neurosci. Res. 49, 342354.
  • Ek M., Arias C., Sawchenko P. and Ericsson-Dahlstrand A. (2000) Distribution of the EP3 prostaglandin E (2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J. Comp. Neurol. 428, 520.
  • Fiebich B. L., Hull M., Lieb K., Gyufko K., Berger M. and Bauer J. (1997) Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. J. Neurochem. 68, 704709.
  • Fiebich B. L., Hofer T. J., Lieb K., Hüll M., Butcher R. D., Schumann G., Schulze-Osthoff K. and Bauer J. (1999) The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha. Neuropharmacology 38, 13251333.
  • Fiebich B. L., Schleicher S., Spleiss O., Czygan M. and Hull M. (2001) Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J. Neurochem. 79, 950958.
  • Gebicke-Haerter P. J., Bauer J., Schobert A. and Northoff H. (1989) Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J. Neurosci. 9, 183194.
  • Gschwendt M., Muller H. J., Kielbassa K., Zang R., Kittstein W., Rincke G. and Marks F. (1994) Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199, 9398.
  • Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H. J. and Johannes F. J. (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392, 7780.
  • Hata A. N. and Breyer R. M. (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103, 147166.
  • Hayaishi O. (1991) Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2. FASEB J. 5, 25752581.
  • Hehner S. P., Heinrich M., Bork P. M., Vogt M., Ratter F., Lehmann V., Schulze-Osthoff K., Droge W. and Schmitz M. L. (1998) Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J. Biol. Chem. 273, 12881297.
  • Hehner S. P., Hofmann T. G., Droge W. and Schmitz M. L. (1999) The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J. Immunol. 163, 56175623.
  • Hoozemans J. J., Rozemuller A. J., Janssen I., De Groot C. J., Veerhuis R. and Eikelenboom P. (2001) Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol. (Berl.) 101, 28.
  • Horiguchi S., Ueno R., Hyodo M. and Hayaishi O. (1986) Alterations in nociception after intracisternal administration of prostaglandin D2, E2 or F2 alpha to conscious mice. Eur. J. Pharmacol. 122, 173179.
  • Hull M., Lieb K. and Fiebich B. L. (2002) Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs. Curr. Med. Chem. 9, 8388.
  • Iadecola C. and Alexander M. (2001) Cerebral ischemia and inflammation. Curr. Opin. Neurol. 14, 8994.
  • Iadecola C., Forster C., Nogawa S., Clark H. B. and Ross M. E. (1999) Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol. (Berl.) 98, 914.
  • Iwasaki K., Noguchi K., Endo H., Kondo H. and Ishikawa I. (2003) Prostaglandin E2 downregulates interleukin-12 production through EP4 receptors in human monocytes stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans and interferon-gamma. Oral Microbiol. Immunol. 18, 150155.
  • Kim S. J., Chang Y. Y., Kang S. S. and Chun J. S. (1997) Phorbol ester effects in atypical protein kinase C zeta overexpressing NIH3T3 cells: possible evidence for crosstalk between protein kinase C isoforms. Biochem. Biophys. Res. Commun. 237, 336339.
  • Kishore N., Sommers C., Mathialagan S. et al. (2003) A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J. Biol. Chem. 278, 32 86132 871.
  • Kitanaka J., Hashimoto H., Gotoh M. et al. (1996) Expression pattern of messenger RNAs for prostanoid receptors in glial cell cultures. Brain Res. 707, 282287.
  • Kotani M., Tanaka I., Ogawa Y., Usui T., Tamura N., Mori K., Narumiya S., Yoshimi T. and Nakao K. (1997) Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics 40, 425434.
  • Kotani M., Tanaka I., Ogawa Y. et al. (2000) Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus. J. Clin. Endocrinol. Metab. 85, 43154322.
  • Kunz T., Marklund N., Hillered L. and Oliw E. H. (2002) Cyclooxygenase-2, prostaglandin synthases, and prostaglandin H2 metabolism in traumatic brain injury in the rat. J. Neurotrauma 19, 10511064.
  • Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680685.
  • Levine A. S. and Morley J. E. (1981) The effect of prostaglandins (PGE2 and PGF2 alpha) on food intake in rats. Pharmacol. Biochem. Behav. 15, 735738.
  • Lieb K., Fiebich B. L., Schaller H., Berger M. and Bauer J. (1996a) Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B. J. Neurochem. 67, 20392044.
  • Lieb K., Kaltschmidt C., Kaltschmidt B., Baeuerle P. A., Berger M., Bauer J. and Fiebich B. L. (1996b) Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373. J. Neurochem. 66, 14961503.
  • Lieb K., Treffurth Y., Hamke M., Akundi R. S., Von Kleinsorgen M. and Fiebich B. L. (2003) Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P receptor. J. Neurochem. 86, 6976.
  • Lieb K., Biersack L., Waschbisch A., Orlikowski S., Akundi R. S., Candelario-Jalil E., Hull M. and Fiebich B. L. (2005) Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells. J. Neurochem. 93, 549559.
  • Lim G. P., Yang F., Chu T. et al. (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 57095714.
  • Lynch A. M. and Lynch M. A. (2002) The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur. J. Neurosci. 15, 17791788.
  • Martiny-Baron G., Kazanietz M. G., Mischak H., Blumberg P. M., Kochs G., Hug H., Marme D. and Schachtele C. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268, 91949197.
  • Matsuoka Y., Furuyashiki T., Bito H. et al. (2003) Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Proc. Natl Acad. Sci. USA 100, 41324137.
  • McCarthy K. D. and De Vellis J. (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890902.
  • McCullough L., Wu L., Haughey N., Liang X., Hand T., Wang Q., Breyer R. M. and Andreasson K. (2004) Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J. Neurosci. 24, 257268.
  • Minghetti L., Greco A., Cardone F., Puopolo M., Ladogana A., Almonti S., Cunningham C., Perry V. H., Pocchiari M. and Levi G. (2000) Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J. Neuropathol. Exp. Neurol. 59, 866871.
  • Molina-Holgado E., Ortiz S., Molina-Holgado F. and Guaza C. (2000) Induction of COX-2 and PGE (2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br. J. Pharmacol. 131, 152159.
  • Moynagh P. N., Williams D. C. and O'Neill L. A. (1993) Interleukin-1 activates transcription factor NF kappa B in glial cells. Biochem. J. 294, 343347.
  • Nakamura K., Kaneko T., Yamashita Y., Hasegawa H., Katoh H., Ichikawa A. and Negishi M. (1999) Immunocytochemical localization of prostaglandin EP3 receptor in the rat hypothalamus. Neurosci. Lett. 260, 117120.
  • Nakamura K., Kaneko T., Yamashita Y., Hasegawa H., Katoh H. and Negishi M. (2000) Immunohistochemical localization of prostaglandin EP3 receptor in the rat nervous system. J. Comp. Neurol. 421, 543569.
  • Nakamura K., Li Y. Q., Kaneko T., Katoh H. and Negishi M. (2001) Prostaglandin EP3 receptor protein in serotonin and catecholamine cell groups: a double immunofluorescence study in the rat brain. Neuroscience 103, 763775.
  • O'Neill L. A. and Greene C. (1998) Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63, 650657.
  • Othman T., Yan H. and Rivkees S. A. (2003) Oligodendrocytes express functional A1 adenosine receptors that stimulate cellular migration. Glia 44, 166172.
  • Palombella V. J., Rando O. J., Goldberg A. L. and Maniatis T. (1994) The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78, 773785.
  • Parker L. C., Luheshi G. N., Rothwell N. J. and Pinteaux E. (2002) IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice. Br. J. Pharmacol. 136, 312320.
  • Pinteaux E., Parker L. C., Rothwell N. J. and Luheshi G. N. (2002) Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 83, 754763.
  • Prasad K. N., La Rosa F. G. and Prasad J. E. (1998) Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid. In Vitro Cell. Dev. Biol. Anim. 34, 265274.
  • Rothwell N. J. and Luheshi G. N. (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618625.
  • Schlotzer-Schrehardt U., Zenkel M. and Nusing R. M. (2002) Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest. Ophthalmol. Vis. Sci. 43, 14751487.
  • Shih S. C., Mullen A., Abrams K., Mukhopadhyay D. and Claffey K. P. (1999) Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J. Biol. Chem. 274, 15 40715 414.
  • Slawik H., Volk B., Fiebich B. and Hull M. (2004) Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum. Neurochem. Int. 45, 653660.
  • Tojima Y., Fujimoto A., Delhase M. et al. (2000) NAK is an IkappaB kinase-activating kinase. Nature 404, 778782.
  • Toullec D., Pianetti P., Coste H. et al. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15 77115 781.
  • Ushikubi F., Segi E., Sugimoto Y. et al. (1998) Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395, 281284.
  • Vela J. M., Molina-Holgado E., Arevalo-Martin A., Almazan G. and Guaza C. (2002) Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol. Cell. Neurosci. 20, 489502.
  • Wang K., Scheel-Toellner D., Wong S. H., Craddock R., Caamano J., Akbar A. N., Salmon M. and Lord J. M. (2003) Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways. J. Immunol. 171, 10351041.
  • Way K. J., Chou E. and King G. L. (2000) Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21, 181187.
  • Wing D. A., Goharkhay N., Hanna M., Naidu Y. M., Kovacs B. W. and Felix J. C. (2003) EP3-2 receptor mRNA expression is reduced and EP3-6 receptor mRNA expression is increased in gravid human myometrium. J. Soc. Gynecol. Invest. 10, 124129.
  • Zhang J. and Rivest S. (1999) Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur. J. Neurosci. 11, 26512668.
  • Zhang P., Miller B. S., Rosenzweig S. A. and Bhat N. R. (1996) Activation of C-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J. Neurosci. Res. 46, 114121.